To investigate whether miR-323-3p inhibition could prevent RasGRF1 reduction after CCH, a miR-323-3p inhibitor (antagomir) was administered to rats through icv injection. The gene discussed is RASGRF1; the disease is columnar cell hyperplasia of the breast.